NCT00270309 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Brown CT, Van Der Meulen J, Mundy AR, Emberton M
Lifestyle and behavioural interventions for men on watchful waiting with uncomplicated lower urinary tract symptoms: a national multidisciplinary survey. BJU Int. 2003 Jul;92(1):53-7.
Brown CT, van der Meulen J, Mundy AR, O'Flynn E, Emberton M
Defining the components of a self-management programme for men with uncomplicated lower urinary tract symptoms: a consensus approach. Eur Urol. 2004 Aug;46(2):254-62; discussion 263.
Newman S, Steed L, Mulligan K
Self-management interventions for chronic illness. Lancet. 2004 Oct 23-29;364(9444):1523-37. Review.

Self-management for Men With Uncomplicated Lower Urinary Tract Symptoms. A Randomised Controlled Trial Against Standard Therapy

Clinical trial NCT00270309 - References